Register now
Nordic Life Science Days 2016
14-15 september 2016
Waterfront, Stockholm, Sweden
© 2023 Bionordic. All Rights Reserved
Nordic Life Science Days 2016
14-15 september 2016
Waterfront, Stockholm, Sweden
© 2023 Bionordic. All Rights Reserved
Extend Your opportunities to listen into pioneering companies from the Medicon Valley life science cluster in Greater Copenhagen Region pitching their investment proposals in Oncology, Neuroscience and Regenerative Medicine.
12:00 – 12:45 Mingling lunch at Medicon Village
12:50 – 13:00 Welcome to Greater Copenhagen Region – the home of Medicon Valley
13:00 – 13:45 Company pitches
13:45 – 14:00 Coffe break and catch up with pitching companies
14:00 – 14:45 Company pitches
14:45 – 15:00 Coffe break and catch up with pitching companies
15:00 – 15:45 Company pitches
15:45 – 16:15 Refreshments and catch up with pitching companies
Hosted by:
Invest in Skåne
SmiLe Incubator
Medeon
Lund University
Medicon Valley Alliance
Medicon Village
Region Skåne
Experience in real life one of Europe’s most innovative life science regions by a tour through the eco-system of Medicon Valley cluster in Skåne, on the Swedish side of the border.
You will be taken through some of the leading R&D infrastructures in Europe like:
Max IV – delivers high-quality X-ray light for research in life science
You will have the tour together in groups of 25 fellow delegates.
12:00 – 12:45 Welcome and lunch
12:45 – 13:30 Max IV
13:45 – 14:30 ESS
14:45 – 16:00 Lund Stem Cell Center & Skåne University hospital ATMP
16:15 – 17:30 Medicon Village and SmiLe incubator
17:30 – 18:00 State of Medicon Valley & inspirational key note speech
18:00 – 21:00 NLSD official Welcome reception @ Medicon Village with food, fun & live music
The Nordic Healthtech and health data scene is a world-leading, vibrant, and pioneering ecosystem. Join us to discuss how to foster strategic partnerships and grow your business. Guests will have the opportunity to mingle with Nordic Healthtech investors, startups and stakeholders. Snacks / drinks served. No delegate pass required.
Arranged by Business Tampere, Health Capital Helsinki, Turku Business region, HealthOulu, Kuopio Health, Health Incubator Helsinki, Norway HealthTech, Oslo Cancer cluster, The Life science cluster (Norway), Norwegian Smart Care Cluster, STUNS Life science, Danish Life Science Cluster, Danish trade council, Business Region Göteborg, Medtech4Health, Medeon, Invest Stockholm, Medicon Valley Alliance, Copenhagen Capacity, EITHealth, Business Finland, Health Data Sweden, Sahlgrenska Science Park, HealthTech Nordic, Fingenious, Nordic Health Lab, DI Life Science.
Transfer to NLSDays 2023 Welcome Reception@Medicon Village by shuttle bus from Bella Center (time schedule TBC)
Hosted by:
Invest in Skåne
SmiLe Incubator
Medeon
Medicon Village
Medicon Valley Alliance
Lund University
Region Skåne
Speakers and presenters are encouraged and expected to bring their own memory device to the speakers ready room, where they will have the opportunity to receive technical assistance, to review their presentations or make any last-minute changes .
If possible, please check-in at the speakers ready room two hours before your presentation!
Nordic countries form a vibrant life science ecosystem built on strong innovative culture, top-notch universities, high quality healthcare system and an industry consisting of a variety of biotech, service providers and big pharma companies. This session dives into the progress of the Nordic life science industry within the past ten years and discusses what is required from the Nordic and European life science sector to stay competitive.
Moderator(s): Ms. Jessica Martinsson - Director General & CEO, SwedenBIO
Speaker(s):
Mr. Olivier Duchamp-Giudicelli - Managing Director, NLSDays - Vice-President, SwedenBIO
Dr. Marjo Puumalainen - Program Director, NLSDays - International Director, SwedenBIO
Ms. Irene Norstedt - Director People Directorate, DG Research and Innovation, European Commission
Mr. Shaun Grady - Senior Vice President, Business Development Operations, AstraZeneca
Ms. Trine Bartholdy - Chief Innovation Officer, BioInnovation Institute
Mr. Daniel Chancellor - Director Thought Leadership - Consulting & Analytics, Citeline
10 selected SMEs will give a four-minute pitch of their companies in front of the investor jury and the conference audience. The two prizes that will be awarded on stage at the NLSDays Closing ceremony are the Merck Advance Biotech Grant Program – Nordics and the NLSDays Nordic Star 2023 Award.
Moderator(s): Ms. Iris Öhrn - Investment Advisor Life Sciences, Business Region Göteborg Mr. David Munis Zepernick - Director, Member Engagement and Communication, Medicon Valley Alliance
Nordic companies have a culture of early IPOs while the level of international investors is relatively low. How should life science companies adjust their business model to become more attractive in the eyes of international investors and pharma scouts? How to turn your business into a golden goose instead of chasing investors?
Moderator(s): Dr. João Ribas - Principal, Novo Holdings
Speaker(s):
Dr. Andreas Schmidt - Senior Vice-President, Singleron
Mr. Kerem Erden - VP, Head of Collaborate to Cure Hub EMEA, Bayer
Dr. Ylva Skoglösa - Partner, Aera
Ms. Agnete Fredriksen - Co-Founder & Chief Business Officer, Nykode Therapeutics
11:00 ProductLifeGroup - Professional Services & Consulting 11:12 ABB Life Sciences - Supplier & Engineering 11:24 CAS - Professional Services & Consulting 11:36 Nordtext - Professional Services & Consulting 11:42 Key2Compliance - Professional Services & Consulting 11:48 Cencora - Professional Services & Consulting
Welcome to a session on Nordic participation in EU public-private partnerships in health research and innovation. This is the opportunity for you as a keyplayer in life science (SMEs, life science industry, academia representative and other stakeholders), to learn more about how to engage with EU calls and collaboration opportunities and to get the most out of it.
The session is hosted by Vinnova in collaboration with Business Finland.
Moderator(s): Dr. Malin Eklund - Programme Manager, Vinnova
Speaker(s):
Ms. Ulrika Warpman Berglund - CEO, Oxcia
Dr. Julius Sipilä - Discovery Data Technology Lead, Orion
Ms. Anette Steenberg - CEO, Medicon Valley Alliance
Dr. Sampo Sammalisto - NCP for Horizon Europe Cluster 1 Health, Business Finland
Interactive workshop on discussing how to ensure more women are reaching leadership positions within life science field and highlight the work that has been done in the Nordics around gender balance.
Moderator(s): Ms. Jessica Martinsson - Director General & CEO, SwedenBIO Ms. Anette Steenberg - CEO, Medicon Valley Alliance
Speaker(s):
Ms. Emma Kate Hopkins - United Kingdom Ambassador to Denmark
Dr. Lene Gerlach - Partner, Eir Ventures & Chairperson, WiLD
Prof. Birgitte Rahbek Kornum - Associate Professor, University of Copenhagen & CEO, Ceremedy
Ms. Helena Strigård - CEO, Haeger & Carlsson
Starting with at presentation of a new Business Sweden report and followed by a panel discussion on investments into innovative Nordic companies.
Moderator(s): Dr. Britta Stenson - Head of Global Industry Network Life Science, Business Sweden
Speaker(s):
Ms. Emma Hemmingson - Senior Project Manager, Business Sweden Paris
Mr. Eric Blomquist - Senior Project Manager, Business Sweden Madrid
Join us for an insightful fireside chat featuring Anthony Gemmell, Senior Director at Johnson & Johnson Innovation, and Bobby Soni, Chief Business Officer at BioInnovation Institute. Together, they will discuss strategies for advancing the life science ecosystem in the Nordics, expanding its footprint. This session will encompass an overview of the Danish system, the challenges in catalyzing startups, and potential opportunities for connecting scientists with the breadth of investment in the region.
Speaker(s):
Mr. Anthony Gemmell - Senior Director, Johnson & Johnson Innovation
Dr. Bobby Soni - Chief Business Officer, BioInnovation Institute
The capability to collect different kinds of health data streams has exploded during the past years, offering great potential to prevent, predict and treat diseases. Integration of data streams and arise of AI offer unique business opportunities for emerging biotech companies, big pharma, and even giant tech companies – all aiming to fulfill the potential of precision health. During this session, the panelists discuss what is required to harness health data to fulfil its full potential to improve our health.
Moderator(s): Dr. C. Mikael Mattsson - CEO, Svexa
Speaker(s):
Prof. Tine Jess - Center Director, PREDICT National Center of Excellence
Mr. Mattias Kyhlstedt - CEO and Founder, Synergus RWE
14:00 CombiGene - Biotechnology - Therapeutics & Diagnostics 14:13 ABLIVA - Biotechnology - Therapeutics & Diagnostics 14:20 omnio - Biotechnology - Therapeutics & Diagnostics 14:27 Gedea Biotech - Biotechnology - Therapeutics & Diagnostics 14:34 Curida Diatec - Biotechnology - Therapeutics & Diagnostics 14:41 Synartro - Biotechnology - Therapeutics & Diagnostics 14:48 MyoPax - Biotechnology - Therapeutics & Diagnostics 14:55 Asgard Therapeutics - Biotechnology - Therapeutics & Diagnostics
10 selected SMEs will give a four-minute pitch of their companies in front of the investor jury and the conference audience. The two prizes that will be awarded on stage at the NLSDays Closing ceremony are the Merck Advance Biotech Grant Program – Nordics and the NLSDays Nordic Star 2023 Award.
Moderator(s): Ms. Iris Öhrn - Investment Advisor Life Sciences, Business Region Göteborg Mr. David Munis Zepernick - Director, Member Engagement and Communication, Medicon Valley Alliance
New drug modalities such as cell and gene therapies and mRNA have shown great potential to cure patients suffering from cancer, infections, and other diseases. The Nordics is a home for several biotech companies developing groundbreaking novel therapies. This session explores what the main opportunities and challenges are related to development, manufacturing, regulatory aspects, and clinical use of new drug modalities.
Moderator(s): Dr. Anders Holmén - VP & Head of Pharmaceutical Sciences, BioPharmaceuticals R&D, AstraZeneca Dr. Ulrica Sehlstedt - Global Practice Leader Healthcare and Life Sciences, Arthur D. Little
Speaker(s):
Dr. Michael May - CEO, Centre for Commercialization of Regenerative Medicine
Dr. Laura Koivusalo - CEO, StemSight
Dr. Falk Ehmann - Head of Innovation and Development Accelerator, European Medicines Agency
16:00 GreinDX - MedTech - Diagnostics 16:07 AMYLOIDIA - MedTech - Diagnostics 16:15 AI Medical Technology - MedTech - Diagnostics 16:23 Realheart - MedTech - Diagnostics 16:30 DoMore Diagnostics - MedTech - Diagnostics 16:38 Chemtronica - Biotechnology - R&D Services 16:45 Mercodia - Biotechnology - Therapeutics & Diagnostics
Speakers and presenters are encouraged and expected to bring their own memory device to the speakers ready room, where they will have the opportunity to receive technical assistance, to review their presentations or make any last-minute changes .
If possible, please check-in at the speakers ready room two hours before your presentation!
Diseases in the central nervous system are devastating for patients and their families and costly for society. Pharma and biotech companies from the Nordics have been actively involved in the recent developments of treatment of Alzheimer’s diseases and other neurological disorders. This session highlights the recent successes in the field of CNS and explores the key factors to advance treatments of CNS diseases.
Moderator(s): Dr. Marc-Olivier Bévierre - Life Science Practice Leader, Vintura
Speaker(s):
Dr. Richard Reschen - Director, Business Development & Licensing, MSD
Dr. Gunilla Osswald - CEO, BioArctic
Dr. Peter Horn Møller - Founder & Partner, Marigold Innovation
09:00 Recipharm - CRO/CMO/CDMO 09:12 AXXAM - CRO/CMO/CDMO 09:24 TFS HealthScience - CRO/CMO/CDMO 09:36 REPROCELL - CRO/CMO/CDMO 09:42 Key2Compliance - Professional Services & Consulting 09:48 Catalent Pharma Solutions - CRO/CMO/CDMO
10 selected SMEs will give a four-minute pitch of their companies in front of the investor jury and the conference audience. The two prizes that will be awarded on stage at the NLSDays Closing ceremony are the Merck Advance Biotech Grant Program – Nordics and the NLSDays Nordic Star 2023 Award.
Moderator(s): Ms. Iris Öhrn - Investment Advisor Life Sciences, Business Region Göteborg Mr. David Munis Zepernick - Director, Member Engagement and Communication, Medicon Valley Alliance
Licensing deals with pharma are crucial part for life science companies. This session will dive into the licensing landscape in 2023. What are the key considerations when negotiating licensing deals and what will sell in the future?
Moderator(s): Dr. Marjo Puumalainen - Program Director, NLSDays - International Director, SwedenBIO
Speaker(s):
Mr. Daniel Chancellor - Director Thought Leadership - Consulting & Analytics, Citeline
Dr. Daniel Marshall - Director, Business Development Oncology, MSD
11:00 BioArctic - Pharmaceuticals 11:15 MSD - Pharmaceutical 11:30 AstraZeneca - Pharmaceutical
LINK Medical, as a CRO company, is interested in how we can conduct studies so that they bring as high value as possible for the patients. How can this be done? Listen to KOLs and experts in the field discuss how to increase the value for the patient and secure the quality of the data.
Moderator(s): Dr. Kim Simonsen - Drug Development Expert, Consultant
Speaker(s):
Dr. Anne Börjesson-Hanson - Senior Research Physician, Karolinska University Hospital
Mr. Patrik Åvestrand - CEO, Cliniqnect
Mr. Mario Baban - Group Manager Clinical Data Management, Link Medical
Interactive lunch workshop at NLSDays: ‘Pride and Prejudice: Are VCs and start-ups on the same page?
To close a deal, VCs and start-ups need to understand each other. This workshop gathers VCs and start-ups to discuss ‘prejudices’ that arise on each side of the funding table.
EVERSANA’s moderator will be joined by panelists from large pharma, biotech and research to dive into options beyond the traditional partnering structures.? Each potential structure will be explored to understand the potential opportunities and challenges associated with the development and commercialisation of a novel asset.
Moderator(s): Ms. Ashley Cox - Partner & Head of Europe, Eversana - Regional Chair Northern Europe, Healthcare Businesswomen's Association
In the final stage program of the Nordic Life Science Days 2023 we invite you to look ahead into a prosperous future of life sciences, by handing out awards to our academic innovation projects and young companies.
The two prizes that will be awarded on stage at the NLSDays Closing ceremony are:
We also serve you the highlights of a decade of Nordic Life Science partnering, as well as the helicopter perspective of the days you have just experienced. We also bid you farewell and au revoir!
